Finance

Lists
Why is CRBP down 9,30%?
Dive Deeper
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
US$4,78
-9,30%
(-0,49) 1D
US$4,78
0,00% (0,00)
After hours
Closed: 13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
US$5,24
High
US$5,26
Low
US$4,76
Mkt. cap
92,45 ລ້ານ
Avg. vol.
1,21 ລ້ານ
Volume
647,33 ພັນ
52-wk high
US$20,56
52-wk low
US$4,76
EPS
US$-6,17
Beta
2,63
Shares outstanding
19,34 ລ້ານ
No. of employees
36
Open
US$5,24
High
US$5,26
Low
US$4,76
Mkt. cap
92,45 ລ້ານ
Avg. vol.
1,21 ລ້ານ
Volume
647,33 ພັນ
52-wk high
US$20,56
52-wk low
US$4,76
EPS
US$-6,17
Beta
2,63
Shares outstanding
19,34 ລ້ານ
No. of employees
36
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
Founded1 ມ.ກ. 2009
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current US$4,78
US$48,00 (+904,18%)
Average
US$36,67 (+667,15%)
Lowest
US$30,00 (+527,62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
US$30,00
+527,6%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$35,00
+632,2%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
US$38,00
+695%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
US$33,00
+590,4%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$36,00
+653,1%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
US$48,00
+904,2%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$48,00
+904,2%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
US$45,00
+841,4%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
US$38,00
+695%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
US$33,00
+590,4%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
US$28,00
+485,8%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
20,86 ລ້ານ
18,41 ລ້ານ
19,82 ລ້ານ
31,18 ລ້ານ
Cost of revenue
20,86 ລ້ານ
18,41 ລ້ານ
19,82 ລ້ານ
31,18 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,56 ລ້ານ
3,56 ລ້ານ
4,48 ລ້ານ
5,02 ລ້ານ
Operating expense
3,56 ລ້ານ
3,56 ລ້ານ
4,48 ລ້ານ
5,02 ລ້ານ
Total operating expenses
24,42 ລ້ານ
21,97 ລ້ານ
24,30 ລ້ານ
36,19 ລ້ານ
Operating income
-24,42 ລ້ານ
-21,97 ລ້ານ
-24,30 ລ້ານ
-36,19 ລ້ານ
Other non operating income
-50,00 ພັນ
-1,10 ລ້ານ
-67,00 ພັນ
-11,00 ພັນ
EBT including unusual items
-23,34 ລ້ານ
-20,56 ລ້ານ
-22,97 ລ້ານ
-35,04 ລ້ານ
EBT excluding unusual items
-23,34 ລ້ານ
-21,66 ລ້ານ
-22,97 ລ້ານ
-35,04 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23,34 ລ້ານ
-20,56 ລ້ານ
-22,97 ລ້ານ
-35,04 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-1,90
-1,25
-1,23
-1,81
Interest and investment income
1,12 ລ້ານ
1,41 ລ້ານ
1,40 ລ້ານ
1,16 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
1,12 ລ້ານ
1,41 ລ້ານ
1,40 ລ້ານ
1,16 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-24,37 ລ້ານ
-21,92 ລ້ານ
-24,26 ລ້ານ
-36,14 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google